Results
|
1.
|
Use of Imaging Endpoints in Clinical Trials. [Review] MedStar authors:
Year: 2017
Citation: - Jacc: Cardiovascular Imaging. 10(3):296-303, 2017 Mar
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Gillam LD, Leipsic J, Weissman NJ
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial. MedStar authors:
Year: 2016
Citation: - Diabetes Care. 39(11):1972-1980, 2016 Nov
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Aroda VR, Bellido D, Bergenstal RM, Gonzalez-Galvez G, Guo H, LixiLan-L Trial Investigators, Niemoeller E, Rosenstock J, Souhami E, Takami A, Unger J, Wysham C
|
|
6.
|
Critical Appraisal of Contemporary Clinical Endpoint Definitions in Coronary Intervention Trials: A Guidance Document. [Review] MedStar authors:
Year: 2019
Citation: - Jacc: Cardiovascular Interventions. 12(9):805-819, 2019 05 13.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Brown KJ, Cutlip DE, de Vries T, Garcia-Garcia HM, Held C, Lopes RD, McFadden E, Menon V, Onuma Y, Seltzer JH, Serruys PW, Soliman OII, Spitzer E, Stone GW, Vranckx P
|